Sumner J W, Sims K G, Jones D C, Anderson B E
Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Vaccine. 1995 Jan;13(1):29-35. doi: 10.1016/0264-410x(95)80007-z.
Baculovirus recombinants that express the Rickettsia rickettsii rOmpA protein were constructed. Monoclonal antibodies (mAbs) against the rOmpA protein reacted with recombinant-infected Spodoptera frugiperda (Sf9) cells in indirect immunofluorescence assays. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting of infected Sf9 cell lysates with a mAb against rOmpA showed that the recombinant-expressed rOmpA protein migrated slightly below rOmpA extracted from R. rickettsii. Guinea-pigs immunized with lysates of recombinant-infected Sf9 cells developed antibodies reactive with R. rickettsii and were protected against challenge, indicating that the baculovirus-expressed rOmpA protein could be useful in subunit vaccines and for studies of the immune response to R. rickettsii infection.
构建了表达立氏立克次体rOmpA蛋白的杆状病毒重组体。在间接免疫荧光试验中,针对rOmpA蛋白的单克隆抗体(mAb)与重组感染的草地贪夜蛾(Sf9)细胞发生反应。用抗rOmpA的单克隆抗体对感染的Sf9细胞裂解物进行十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和免疫印迹分析,结果显示重组表达的rOmpA蛋白迁移位置略低于从立氏立克次体中提取的rOmpA。用重组感染的Sf9细胞裂解物免疫豚鼠,豚鼠产生了与立氏立克次体反应的抗体,并受到保护免受攻击,这表明杆状病毒表达的rOmpA蛋白可用于亚单位疫苗以及对立氏立克次体感染免疫反应的研究。